BVT announced today that it has entered a third year of sunflower trials using BVT’s proprietary dispenser system that utilizes bumble bees to efficiently deliver its patented microbial-based organic biofungicide, BVT-CR7 to control fungal disease. In sunflowers the fungal disease sclerotinia causes high levels of crop loss and there are currently no effective, economically viable, treatments.
BVT announced today that its management was recently selected to present and participated at two major industry events during July.
BVT announced today that it has hired Everett Hendrixon as Territory Manager to drive its sales efforts in Florida and the southeastern U.S. Hendrixon, with a background in agri-business administration and consulting, comes to BVT with a passion for the industry and a firm belief that the science of using natural pest control agents as organic solutions leads to better farms and better food.
BVT announced today that it has submitted registration documents in Switzerland for its proprietary active ingredient, Clonostachys rosea CR-7 for use against fungal diseases in production agriculture. Switzerland uses approximately CDN$40 million/year in chemical fungicides where growers are increasingly seeking non-chemical alternatives and represents the company’s beachhead into Europe. The entire European fungicide and insecticide market is approximately CDN $9.0 billion, of which approximately CDN$1.0 billion is a target for BVT’s bee delivery system.
BVT today provided a corporate update and review of current business initiatives. Development of BVT’s vectoring delivery system, utilizing VECTORITETM with CR-7, is largely complete so the primary objective is now full commercial launch in the US. Second to this is the selective expansion into markets outside the US, across crop varieties, and through strategic or synergistic product development.
BVT is pleased to announce the closing of its non-brokered private placement of 500,000 units of the Company at a price of $0.25 per unit for gross proceeds of C$125,000 (the “Offering”). Each unit consists of one common share and one common share purchase warrant (“Unit”). Each common share purchase warrant (“Warrant”) entitles the holder to purchase one additional common share at a price of C$0.35 per common share until May 2, 2020.
BVT is pleased to provide an update on its work in the Florida strawberry market this past winter. Five notable, Florida-based strawberry growers used BVT’s proprietary crop production system starting in late December 2017 through March 2018 across 13 fields and covering a total of over 170 acres.
BVT is pleased to announce the appointment of Brandon Boddy to the board of directors of BVT. Brandon contributes 14 years of capital markets experience and directly as a principal. Mr. Boddy is a founding director of both Cannabis Wheaton Income Corp. and Global Blockchain Technologies Corp. From 2006 to 2014, Brandon acted in the capacity of Vice President at Canaccord Financial Inc., as well as Principal and Senior Vice President at Jordan Capital Markets.
BVT is pleased to announce that it has received two new key patent application allowances.
BVT is pleased to announce the closing of its non-brokered private placement of 12,000,000 units of the Company at a price of $0.25 per unit for gross proceeds of C$3,000,000 (the “Offering”). Each unit consists of one common share and one common share purchase warrant (“Unit”). Each common share purchase warrant (“Warrant”) entitles the holder to purchase one additional common share at a price of C$0.35 per common share until March 28, 2020.
Connect with us
Have a question about BVT, the bee vectoring process, sustainable farming practices or just want to share feedback? We want to hear from you!